IMC Chicago’s Novo Nordisk NVO Stock Holding History

IMC Chicago’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-802,198	Closed	-$34.5M	–	6647
2026 Q1	$29.5M	Buy	802,198 +694,983	+648%	+$32.9M	0.01%	693
2025 Q4	$5.46M	Sell	107,215 -175,955	-62%	-$9M	﹤0.01%	1670
2025 Q3	$15.7M	Buy	283,170 +4,627	+2%	+$271K	0.01%	895
2025 Q2	$19.2M	Sell	278,543 -35,942	-11%	-$2.44M	0.01%	714
2025 Q1	$21.8M	Buy	314,485 +258,480	+462%	+$21.3M	0.01%	536
2024 Q4	$4.82M	Sell	56,005 -10,395	-16%	-$1.12M	﹤0.01%	1252
2024 Q3	$7.91M	Buy	+66,400	New	+$8.86M	﹤0.01%	924

Other funds holding NVO

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

IMC Chicago's NVO Position: Q2 2026 in Review

IMC Chicago sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 802,198 shares — an estimated $34.5M sold.

IMC Chicago first reported a position in NVO in Q3 2024 and held it in 7 quarters. The position peaked at $29.5M in Q1 2026. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

IMC Chicago reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
IMC Chicago sold 802,198 Novo Nordisk shares in Q2 2026, an estimated $34.5M.
IMC Chicago first reported a position in Novo Nordisk in Q3 2024 and held it in 7 quarters.
IMC Chicago's Novo Nordisk position peaked at $29.5M in Q1 2026.
819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.